Elevated Mitral Valve Pressure Gradient Is Predictive of Long‐Term Outcome After Percutaneous Edge‐to‐Edge Mitral Valve Repair in Patients With Degenerative Mitral Regurgitation (MR), But Not in Functional MR

Autor: Miriam Ulrich, Peter Seizer, Wenzhong Zhang, Fabian Bamberg, Matthias Mezger, Annika Becker, Juergen Schreieck, Johannes Patzelt, Mohammed F. Saad, Tara A.E. Patzelt, Peter Boekstegers, Henry Nording, Reinhard Sauter, Christian Schlensak, Harald F. Langer, Volker Rudolph, Meinrad Gawaz, Ingo Eitel
Jazyk: angličtina
Rok vydání: 2019
Předmět:
mitral valve
Male
Cardiac Catheterization
Percutaneous
Complications
Mitral Valve Annuloplasty
medicine.medical_treatment
Kaplan-Meier Estimate
030204 cardiovascular system & hematology
Severity of Illness Index
0302 clinical medicine
Catheter-Based Coronary and Valvular Interventions
Mitral valve
030212 general & internal medicine
Original Research
Aged
80 and over

mitral valve regurgitation
Mitral Valve Insufficiency
Prognosis
medicine.anatomical_structure
Treatment Outcome
Echocardiography
Cardiology
Female
Cardiology and Cardiovascular Medicine
Mitral valve regurgitation
Percutaneous Mitral Valve Repair
mitral stenosis
Reoperation
medicine.medical_specialty
03 medical and health sciences
Internal medicine
medicine
Pressure
Humans
In patient
percutaneous mitral valve repair
Mortality
Pressure gradient
Aged
Proportional Hazards Models
Mitral regurgitation
Mitral valve repair
business.industry
percutaneous treatment
Hemodynamics
medicine.disease
Valvular Heart Disease
Heart-Assist Devices
business
Zdroj: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
ISSN: 2047-9980
Popis: Background This study analyzed the effects on long‐term outcome of residual mitral regurgitation ( MR ) and mean mitral valve pressure gradient ( MVPG ) after percutaneous edge‐to‐edge mitral valve repair using the MitraClip system. Methods and Results Two hundred fifty‐five patients who underwent percutaneous edge‐to‐edge mitral valve repair were analyzed. Kaplan–Meier and Cox regression analyses were performed to evaluate the impact of residual MR and MVPG on clinical outcome. A combined clinical end point (all‐cause mortality, MV surgery, redo procedure, implantation of a left ventricular assist device) was used. After percutaneous edge‐to‐edge mitral valve repair, mean MVPG increased from 1.6±1.0 to 3.1±1.5 mm Hg ( P MR severity to ≤2+ postintervention was achieved in 98.4% of all patients. In the overall patient cohort, residual MR was predictive of the combined end point while elevated MVPG >4.4 mm Hg was not according to Kaplan–Meier and Cox regression analyses. We then analyzed the cohort with degenerative and that with functional MR separately to account for these different entities. In the cohort with degenerative MR , elevated MVPG was associated with increased occurrence of the primary end point, whereas this was not observed in the cohort with functional MR . Conclusions MVPG >4.4 mm Hg after MitraClip implantation was predictive of clinical outcome in the patient cohort with degenerative MR . In the patient cohort with functional MR , MVPG >4.4 mm Hg was not associated with increased clinical events.
Databáze: OpenAIRE